Full notice text
Scope
Procurement description
The following medicines will be included in the tender:- Apremilast; Denosumab; Ferric Carboxymaltose; Pazopanib.
Total value (estimated)
15902104 GBP Excluding VAT
19082525 GBP Including VAT
Contract dates (estimated)
01 March 2026, 00:00AM to 29 February 2028, 23:59PM
Extension end date (if all the extensions are used): 28 February 2030
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Procedure
Is the total value above threshold?
Above threshold
Lots
Divided into 1 lots
Lot number: 1
CPV classifications
- 33600000 - Pharmaceutical products
Sustainability
Small and medium-sized enterprises (SME)
Voluntary, community and social enterprises (VCSE)
Contract start date (estimated)
01 March 2026, 00:00AM
Contract end date (estimated)
29 February 2028, 23:59PM
Extension end date (estimated)
28 February 2030, 23:59PM
Can the contract be extended?
Yes
Engagement
Engagement process description
This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).
There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Rachelle Elvin (rachelle.elvin@wales.nhs.uk).
Due date
27 November 2025, 23:59PM
Has the engagement period already ended?
No
Submission
Publication date of tender notice (estimated)
27 November 2025
Coding
Commodity categories
| ID |
Title
|
Parent category
|
|
There are no commodity categories for this notice.
|
Delivery locations
| ID |
Description
|
| 100 |
UK - All |
About the buyer
- Main contact:
- n/a
- Admin contact:
- n/a
- Technical contact:
- n/a
- Other contact:
- n/a